These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 21512182)

  • 1. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR).
    Wang Y; Liao X; Zhao X; Wang DZ; Wang C; Nguyen-Huynh MN; Zhou Y; Liu L; Wang X; Liu G; Li H; Wang Y;
    Stroke; 2011 Jun; 42(6):1658-64. PubMed ID: 21512182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist Impact on Ischemic Stroke Care in the Emergency Department.
    Gosser RA; Arndt RF; Schaafsma K; Dang CH
    J Emerg Med; 2016 Jan; 50(1):187-93. PubMed ID: 26412104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Emergency Medical Services and Timely Treatment Among Ischemic Stroke.
    Gu HQ; Rao ZZ; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Wang CY; Liu C; Li H; Li ZX; Xiao RP; Wang YJ;
    Stroke; 2019 Apr; 50(4):1013-1016. PubMed ID: 30841820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10-year Temporal Trends of Intravenous Thrombolysis in Acute Ischemic Stroke: Analysis of the China National Stroke Registry I-Ⅲ.
    Jia W; Jiang Y; Ma R; Huang X; Gu H; Meng X; Li H; Zhao X; Wang Y; Wang Y; Li Z; Wang C
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107431. PubMed ID: 37951082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posterior circulation stroke is associated with prolonged door-to-needle time.
    Sarraj A; Medrek S; Albright K; Martin-Schild S; Bibars W; Vahidy F; Grotta JC; Savitz SI
    Int J Stroke; 2015 Jul; 10(5):672-8. PubMed ID: 23521891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACT-FAST: a quality improvement project to increase the percentage of acute stroke patients receiving intravenous thrombolysis within 60 minutes of arrival at the emergency department.
    Chiu LQ; Quek DYJ; Salihan RB; Ng WM; Othman RB; Lee CH; Oh DCT
    Singapore Med J; 2021 Sep; 62(9):476-481. PubMed ID: 32227791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the implementation of a 24-hr stroke thrombolysis emergency treatment for patients with acute ischaemic stroke.
    Zhao J; Li X; Liang Y; Zhao L; Zhang X; Liu Y
    J Clin Nurs; 2018 May; 27(9-10):2161-2167. PubMed ID: 29345016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving timely treatment with a stroke emergency map: The case of northern China.
    Zhang T; Zhang X; Sun H; Zhou F; Lin S; Sang H; Zheng N; Zhao Z; Shi J; Li W
    Brain Behav; 2020 Aug; 10(8):e01743. PubMed ID: 32652889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
    Kent DM; Price LL; Ringleb P; Hill MD; Selker HP
    Stroke; 2005 Jan; 36(1):62-5. PubMed ID: 15569865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China.
    Wang HY; Gu HQ; Zhou Q; Jiang YY; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Li H; Liu C; Li ZX; Wang YJ; Jiang Y
    BMJ Open; 2022 Jun; 12(6):e055055. PubMed ID: 35750455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke thrombolysis: having more time translates into delayed therapy: data from the Austrian Stroke Unit Registry.
    Ferrari J; Knoflach M; Kiechl S; Willeit J; Matosevic B; Seyfang L; Lang W;
    Stroke; 2010 Sep; 41(9):2001-4. PubMed ID: 20689080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke.
    You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS
    Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.
    Gumbinger C; Reuter B; Stock C; Sauer T; Wiethölter H; Bruder I; Rode S; Kern R; Ringleb P; Hennerici MG; Hacke W;
    BMJ; 2014 May; 348():g3429. PubMed ID: 24879819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.